MBAI — Medbright AI Investments Cashflow Statement
0.000.00%
Last trade - 00:00- CA$5.52m
- CA$4.96m
- 32
- 16
- 20
- 11
Annual cashflow statement for Medbright AI Investments, fiscal year end - February 29th, CAD millions except per share, conversion factor applied.
2020 February 29th | 2021 February 28th | 2022 February 28th | C2023 February 28th | 2024 February 29th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.73 | -0.719 | -1.21 | -0.43 | -7.16 |
| Non-Cash Items | 2.42 | 0.57 | 0.327 | -0.006 | 5.83 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.25 | -0.031 | -0.019 | 0.039 | -0.326 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.052 | -0.18 | -0.898 | -0.397 | -1.65 |
| Capital Expenditures | — | -0.15 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.13 | 0 | -0.313 | -0.881 | -1.14 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.13 | -0.15 | -0.313 | -0.881 | -1.14 |
| Financing Cash Flow Items | -0.007 | -0.004 | -0.032 | 0 | -0.279 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.23 | 0.377 | 2.38 | 0 | 4.37 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.046 | 0.047 | 1.17 | -1.28 | 1.57 |